MicroRNAs as Targets for Cancer Diagnosis: Interests and Limitations

Behrouz Shademan ¹ , Vahidreza Karamad ¹ , Alireza Nourazarian ², Sepideh Masjedi ³, Alireza Isazadeh ⁴, Fatma Sogutlu ¹, Cigir Biray Avcı ¹ *

Cited by CrossRef: 12

1- Shademan B, Yousefi H, Nourazarian A. Methylglyoxal Affects the Expression of miR-125b, miR-107, and Oxidative Stress Pathway-associated Genes in the SH-SY5Y Cell Line. Adv Pharm Bull. 2024;14(2):419 [Crossref]

2- Zhao C, Tang Q, Yang C, Zhou L, Peng J, Zhang T, Zhou S, Li Y. Stereotactic body radiation therapy suppresses myeloid-derived suppressor cells by regulating miR-21/Sorbin and SH3 Domain-containing Protein 1 axis. Hum Exp Toxicol. 2024;43 [Crossref]

3- Chauhan P, Pramodh S, Hussain A, Elsori D, Lakhanpal S, Kumar R, Alsaweed M, Iqbal D, Pandey P, Al Othaim A, Khan F. Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses. Front Cell Dev Biol. 2024;12 [Crossref]

4- Benedusi M, Lee H, Lim Y, Valacchi G. Oxidative State in Cutaneous Melanoma Progression: A Question of Balance. Antioxidants. 2024;13(9):1058 [Crossref]

5- Ware A, Satyamoorthy K, Paul B. CmirC update 2024: a multi-omics database for clustered miRNAs. Funct Integr Genomics. 2024;24(4) [Crossref]

6- Uno H, Takeuchi H, Abe I, Yoshino T, Taguchi T, Hirakawa Y, Matsunaga T, Tanaka T. PCR‐ and wash‐free detection of serum miRNA via signaling probe hybridization. Biotech & Bioengineering. 2025;122(1):159 [Crossref]

7- Banack S, Dunlop R, Mehta P, Mitsumoto H, Wood S, Han M, Cox P. A microRNA diagnostic biomarker for amyotrophic lateral sclerosis. 2024;6(5) [Crossref]

8- Mohseni M, Behzad G, Farhadi A, Behroozi J, Mohseni H, Valipour B. MicroRNAs regulating autophagy: opportunities in treating neurodegenerative diseases. Front Neurosci. 2024;18 [Crossref]

9- Grover S, Gupta S. Automated diagnosis and classification of liver cancers using deep learning techniques: a systematic review. Discov Appl Sci. 2024;6(10) [Crossref]

10- Chen H. microRNA-Based Cancer Diagnosis and Therapy. IJMS. 2023;25(1):230 [Crossref]

11- Kronstein-Wiedemann R, Künzel S, Thiel J, Tonn T. Role of MiRNA in the Regulation of Blood Group Expression. Transfus Med Hemother. 2024;51(4):237 [Crossref]

12- Abolhasanzadeh N, Sarabandi S, Dehghan B, Karamad V, Avci C, Shademan B, Nourazarian A. Exploring the intricate relationship between miRNA dysregulation and breast cancer development: insights into the impact of environmental chemicals. Front Immunol. 2024;15 [Crossref]

13- Chen Y, Cheng C, Chen L. Multifaceted role of microRNA-301a in human cancer: from biomarker potential to therapeutic targeting. Cancer Gene Ther. 2024;31(12):1754 [Crossref]

14- Anvari S, Nikbakht M, Vaezi M, Amini-Kafiabad S, Ahmadvand M. Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies. Cancer Cell Int. 2024;24(1) [Crossref]